Apresol is NOT a standard antihypertensive medication and does not appear in current hypertension treatment guidelines
I cannot provide dosing recommendations for "Apresol" for hypertension because this medication is not recognized as a standard treatment for hypertension in any major clinical guidelines 1, 2, 3, 4. The term "Apresol" does not appear in the 2020 International Society of Hypertension, 2024 ESC, 2017/2025 ACC/AHA, or other major hypertension guidelines.
Critical Clarification Needed
You may be confusing two different medications:
1. Hydralazine (brand name: Apresoline)
- A direct-acting arterial vasodilator
- Used for hypertension, particularly in specific populations
- NOT first-line therapy for routine hypertension 1, 2
2. Isosorbide Dinitrate (ISDN)
- A nitrate vasodilator
- NOT recommended for routine hypertension treatment in any current guideline
- Research shows some efficacy in hypertensive emergencies 5, 6, 7, but this is not guideline-endorsed practice
If You Mean Hydralazine (Apresoline):
Hydralazine is reserved for resistant hypertension as a 4th or 5th-line agent when first-line medications (ACE inhibitors/ARBs, calcium channel blockers, thiazide diuretics) have failed 1.
Standard Dosing Algorithm:
- Initial dose: 10 mg orally 2-4 times daily
- Titration: Increase by 10-25 mg every 2-5 days as tolerated
- Maintenance: 25-100 mg 2-4 times daily
- Maximum: 300 mg/day in divided doses
Elderly Patients:
- Start at lower end of dosing range (10 mg twice daily)
- Titrate more slowly due to increased risk of hypotension 8
- Monitor for orthostatic hypotension carefully
Renal Impairment:
- No specific dose adjustment required for hydralazine, as it undergoes hepatic metabolism
- However, use caution and monitor blood pressure response closely
- For isosorbide dinitrate specifically, no dose adjustment needed in renal insufficiency - pharmacokinetic studies show no drug accumulation even with severe renal impairment 9
Current Guideline-Recommended Approach for Hypertension:
First-line therapy should be:
- Non-Black patients: ACE inhibitor or ARB, then add calcium channel blocker or thiazide diuretic 1, 2
- Black patients: Calcium channel blocker or thiazide diuretic as initial therapy 1
- Elderly/frail patients (>80 years): Consider monotherapy initially, individualize based on frailty 1
Target blood pressure: <130/80 mmHg for most adults, individualized for elderly based on frailty 1, 2
Common Pitfalls to Avoid:
- Do not use hydralazine as first-line therapy - it causes reflex tachycardia and fluid retention
- Do not use isosorbide dinitrate for chronic hypertension management - no guideline support, risk of tolerance
- Do not confuse hypertensive emergency management with chronic hypertension treatment - the research on ISDN is primarily in acute settings 5, 6, 7
Please clarify which specific medication you are asking about, or confirm the clinical indication (routine hypertension vs. heart failure vs. hypertensive emergency) for more precise guidance.